Breath-Based Clinical Trial Targets Early Cancer Detection
The study will recruit up to 3,000 patients across 21 sites in the UK and Europe.
Read More
Search Results for: lung cancer
Biodesix Test Nets Expanded Coverage
With the positive coverage determination from Wellmark BCBS of Iowa and South Dakota, approximately 210 million Americans now have insurance coverage for VeriStrat.
Read More
FISH Probes Assist in Lung Cancer Diagnosis
New probes facilitate the diagnosis and stratified treatment of non-small cell lung cancer.
Read More
Building a Safer Blood Supply
In recent years, challenges to the safety of the nation’s blood supply include a rising understanding of the risks involved in blood transfusions, threats related to known infectious diseases, and the emergence of new pathogens.
Read More
Horizon BCBS of New Jersey Provides Coverage for Biodesix VeriStrat Test
The blood-based proteomic test for patients with advanced non-small cell lung cancer is now covered for another 3.8 million patients living in eastern United States.
Read More